4//SEC Filing
Schneyer Mark C. 4
Accession 0001899977-25-000006
CIK 0001070494other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 6:00 PM ET
Size
13.9 KB
Accession
0001899977-25-000006
Insider Transaction Report
Form 4
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-11-17+9,913→ 63,600 total - Exercise/Conversion
Common Stock
2025-11-17+9,913→ 53,687 total - Sale
Common Stock
2025-11-18$23.69/sh−10,262$243,114→ 53,338 total - Exercise/Conversion
Restricted Stock Units
2025-11-17−9,913→ 0 total→ Common Stock (9,913 underlying) - Exercise/Conversion
Restricted Stock Units
2025-11-17−9,913→ 0 total→ Common Stock (9,913 underlying)
Footnotes (6)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes 327 shares of the Issuer's common stock acquired by the reporting person on November 14, 2025 pursuant to an employee stock purchase plan.
- [F3]The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.69 to $23.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F5]The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date.
- [F6]The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001899977
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 6:00 PM ET
- Size
- 13.9 KB